Safety and Tolerability As with many metabolic therapies, the most commonly reported side effects in the Retatrutide trial included gastrointestinal symptoms such as nausea, diarrhea, constipation, vomiting, and decreased appetite, patterns seen with many gut-hormone modulators
Keywords: obesity, adiposity, insulin resistance, overweight, weight loss 1
Temporary side effects may include redness, swelling, and mild irritation
Q: Can I use one 5mg vial for the entire protocol
A1C should typically be monitored every 3 months until stable, with more frequent visits during dose titration to assess tolerability
It is also described as complementary (not redundant) with tesamorelin or sermorelin, since both of those are GHRH analogs that pair with ipamorelin's GHRP action rather than duplicating it